eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/1999
vol. 3
 
Share:
Share:
abstract:

New aromataze inhibitor (letrozol) in treatment of advanced breast cancer

Janusz Skowronek

Współcz Onkol (1999) 4, 154-155
Online publish date: 2003/08/05
View full text Get citation
 
Patients with advanced breast cancer constitute 4 to 20% of patients with breast cancer. Results of treatment are still disappointing. Drugs like aromatase inhibitors decrease biosynthesis of estrogens which stymulate tumor growth, they prove to be especially effecive in treatment of advanced breast cancer in postmenopausal women with hormonal-dependent breast cancer.
In this paper the new aromatase inhibitor (letrozol) is described. Indication for treatment, contrindications and adverse experiences are presented. Efficacy of treatment of advanced breast cancer patients with letrozol and others aromatase inhibitors is compared.
keywords:

aromatase inhibitors, letrozol, advanced breast cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.